BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wainwright P, Scorletti E, Byrne CD. Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis. Curr Diab Rep 2017;17. [DOI: 10.1007/s11892-017-0851-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Yue Z, Pei L, Meng G, Zhang A, Li M, Jia M, Wang H, Cao L. Simultaneous Quantification of Serum Lipids and Their Association with Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer. Metabolites 2023;13. [PMID: 36677015 DOI: 10.3390/metabo13010090] [Reference Citation Analysis]
2 Onikanni SA, Lawal B, Bakare OS, Ajiboye BO, Ojo OA, Farasani A, Kabrah SM, Batiha GE, Conte-Junior CA. Cancer of the Liver and its Relationship with Diabetes mellitus. Technol Cancer Res Treat 2022;21:15330338221119743. [PMID: 36533882 DOI: 10.1177/15330338221119743] [Reference Citation Analysis]
3 Chou OHI, Ning J, Chiu Chan RN, Chung CT, Huang H, Ng K, Dee EC, Lee S, Kaewdech A, Liu T, Jing F, Yung Cheung BM, Tse G, Zhou J. Lower risks of sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset non-alcoholic fatty liver disease and hepatocellular carcinoma in type 2 diabetes mellitus: A population-based study.. [DOI: 10.1101/2022.08.16.22278847] [Reference Citation Analysis]
4 Rossetto A, Rosignoli A, Tatani B, De Re V, Uzzau A. Hepatic Progression of Hepatocellular Carcinoma. Liver Cancer - Genesis, Progression and Metastasis [Working Title] 2022. [DOI: 10.5772/intechopen.106169] [Reference Citation Analysis]
5 Cao L, Han Y, Pei L, Yue Z, Liu B, Cui J, Jia M, Wang H. A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer. Metabolites 2022;12:610. [DOI: 10.3390/metabo12070610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Reinoso-pereira GL, Paranaguá-vezozzo DC, Mazo DF, França JID, Ono SK, Carrilho FJ. HIGH VALUES OF LIVER STIFFNESS PLAY AN IMPORTANT ROLE IN STRATIFYING THE RISK OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC HEPATITIS C PATIENTS. Arq Gastroenterol 2022;59:204-211. [DOI: 10.1590/s0004-2803.202202000-38] [Reference Citation Analysis]
7 Wang X, Ding S. The biological and pharmacological connections between diabetes and various types of cancer. Pathol Res Pract 2021;227:153641. [PMID: 34619575 DOI: 10.1016/j.prp.2021.153641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
8 Lin CY, Adhikary P, Cheng K. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Adv Drug Deliv Rev 2021;174:127-39. [PMID: 33857552 DOI: 10.1016/j.addr.2021.04.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Stashuk GA, Moisyuk YG, Smirnova DY, Sumtsova OV. The Role of Perfusion Computed Tomography of the Liver in the Assessment of Hemodynamics in Patients with Compensated Cirrhosis of the Liver and the Presence of Type 2 Diabetes Mellitus. Pilot Study. jour 2021. [DOI: 10.52560/2713-0118-2021-2-62-71] [Reference Citation Analysis]
10 Shi T, Kobara H, Oura K, Masaki T. Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes. J Hepatocell Carcinoma 2021;8:45-55. [PMID: 33604315 DOI: 10.2147/JHC.S274933] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
11 Zhang H, Li H, Lan X, Liu F, Li B, Wei Y. Diabetes mellitus affects long-term survival in hepatitis B virus-related hepatocellular carcinoma patients: A propensity score-matched analysis. Medicine (Baltimore) 2021;100:e24354. [PMID: 33530229 DOI: 10.1097/MD.0000000000024354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Targher G, Corey KE, Byrne CD. NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment. Diabetes Metab 2021;47:101215. [PMID: 33296704 DOI: 10.1016/j.diabet.2020.101215] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
13 Wang M, Yang Y, Liao Z. Diabetes and cancer: Epidemiological and biological links. World J Diabetes 2020; 11(6): 227-238 [PMID: 32547697 DOI: 10.4239/wjd.v11.i6.227] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 53] [Article Influence: 17.0] [Reference Citation Analysis]
14 Sanchez-torrijos Y, Ampuero J. The Spectrum of NAFLD: From the Organ to the System. NAFLD and NASH 2020. [DOI: 10.1007/978-3-030-37173-9_1] [Reference Citation Analysis]
15 Jeong H, Kim J, Yang D, Jeong T, Zhao J, Seo JH, Shin DG, Cha J, Han KM, Lim CW, Kim B. Orostachys japonicus A. Berger (Crassulaceae) Exerts Antidiabetic Activity by Improving Glucose and Lipid Levels in Type 2 Diabetic Mice. Journal of Medicinal Food 2019;22:797-809. [DOI: 10.1089/jmf.2018.4391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Li X, Cheng T, He Y, Zhou S, Wang Y, Zhang K, Yu P. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway. Life Sci. 2019;232:116602. [PMID: 31251997 DOI: 10.1016/j.lfs.2019.116602] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
17 Rawla P, Sunkara T, Muralidharan P, Raj JP. Update in global trends and aetiology of hepatocellular carcinoma. Contemp Oncol (Pozn). 2018;22:141-150. [PMID: 30455585 DOI: 10.5114/wo.2018.78941] [Cited by in Crossref: 92] [Cited by in F6Publishing: 118] [Article Influence: 18.4] [Reference Citation Analysis]
18 Li B, Zhang C, Zhan YT. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis. Can J Gastroenterol Hepatol 2018;2018:2784537. [PMID: 30065915 DOI: 10.1155/2018/2784537] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 10.2] [Reference Citation Analysis]
19 Mantovani A, Targher G. Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. Ann Transl Med. 2017;5:270. [PMID: 28758096 DOI: 10.21037/atm.2017.04.41] [Cited by in Crossref: 65] [Cited by in F6Publishing: 75] [Article Influence: 10.8] [Reference Citation Analysis]